Metraipolis › archive › dc_c013b012e8bd
mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions — Europe PMC PMID:38140142
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/38140142
- DOI
- 10.3390/vaccines11121737
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T17:57:11.763Z
- SHA-256 of the archived text
4377804f727e931667c43e1ed8199a05780b7dcfcfeb0aef6430057f99b65f4d- Stable URL of this page
https://metraipolis.com/documento/dc_c013b012e8bd
How to cite
mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions — Europe PMC PMID:38140142 — Europe PMC (en), https://europepmc.org/article/MED/38140142 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c013b012e8bd (Metraipolis archive dc_c013b012e8bd, sha256 4377804f727e931667c43e1ed8199a05780b7dcfcfeb0aef6430057f99b65f4d)
BibTeX
@misc{dcc013b012e8bd,
title = {mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions — Europe PMC PMID:38140142},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/38140142},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c013b012e8bd; sha256 4377804f727e931667c43e1ed8199a05780b7dcfcfeb0aef6430057f99b65f4d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/38140142. Agents can read the archived copy with the MCP tool read_document.